Search
for
Sort by
Research 91–120 of 1000+
- Vemurafenib-induced pityriasis amiantacea: a case report
- The utility of elastic Verhoeff-Van Gieson staining in dermatopathology
- Dermoscopy Research—An Update
- Changing incidence trends of cutaneous B-cell lymphoma
- CUTANEOUS T-CELL LYMPHOMA
- Scalp melanoma: Distinctive high risk clinical and histological features
- Melanotic pigmentation in excisional scar of melanoma patient who received BRAF and MEK inhibitors
- 176 The Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) Study identifies clinical prognostic markers and establishes the foundation for large-scale translational research in cutaneous lymphoma
- Novel small molecules downregulate CDK1 expression and inhibit Wnt/β-catenin signaling in cutaneous squamous cell carcinoma by targeting its distinct tumor-specific cellular landscape
- 571 Role of observation for excisionally biopsied moderately dysplastic nevi with positive histologic margins and risk of development of future melanoma
- Hair shaft miRNA‐221 levels as a new tumor marker of malignant melanoma
- Cutaneous and Mucosal Manifestations Associated with Celiac Disease
- Sentinel lymph node status is the strongest independent predictor for disease free and overall survival in patients with thick melanoma
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- Interferon alfa-2a in the treatment of cutaneous T cell lymphoma
- Cutaneous Scarring: Basic Science, Current Treatments, and Future Directions
- Cutaneous complications of chemotherapeutic agents
- Interferon in the treatment of cutaneous T-cell lymphoma
- Cutaneous and Ocular Late Complications of Sulfur Mustard in Iranian Veterans
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Chronic Stress Suppresses the Expression of Cutaneous Hypothalamic–Pituitary–Adrenocortical Axis Elements and Melanogenesis
- Current management strategies for cutaneous T-cell lymphoma
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Cutaneous necrosis after injection of polyethylene glycol–modified interferon alfa
- Monoolein-alginate beads as a platform to promote adenosine cutaneous localization and wound healing
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Localized cutaneous necrosis associated with the antiphospholipid syndrome
- Immunomodulators in the treatment of cutaneous lymphoma
- Hair Follicle Disruption Facilitates Pathogenesis to UVB-Induced Cutaneous Inflammation and Basal Cell Carcinoma Development in Ptch+/− Mice
- Cutaneous Reactions to Drugs